Less Ads, More Data, More Tools Register for FREE

Pin to quick picksREDX.L Share News (REDX)

  • There is currently no data for REDX

REDX.L News

IN BRIEF: Redx reports positive preclinical data for fibrosis drug
11 May 2023

IN BRIEF: Redx reports positive preclinical data for fibrosis drug

Redx Pharma PLC - Macclesfield, England-based clinical-stage biotechnology company - Announces preclinical data for its lead fibrosis asset, RXC007, a...

TRADING UPDATES: Redx confirms Jounce deal lapses, Tirupati seals deal
3 Apr 2023

TRADING UPDATES: Redx confirms Jounce deal lapses, Tirupati seals deal

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Redx Pharma's bid to buy Jounce snubbed by Concentra's higher offer
27 Mar 2023

Redx Pharma's bid to buy Jounce snubbed by Concentra's higher offer

(Alliance News) - Redx Pharma PLC on Monday noted that Jounce Therapeutics Inc, which it was close to buying, was bought by Concentra Biosciences LLC ...

Jounce agrees Concentra Bioscences takeover, ditches Redx Pharma
27 Mar 2023

Jounce agrees Concentra Bioscences takeover, ditches Redx Pharma

(Sharecast News) - Jounce Therapeutics said on Monday that it was ditching a planned merger with AIM-listed Redx Pharma, opting instead to be bought b...

LONDON MARKET MIDDAY: Stocks down, pound below USD1.19 on US rate view
8 Mar 2023

LONDON MARKET MIDDAY: Stocks down, pound below USD1.19 on US rate view

(Alliance News) - Stock prices in London were lower at midday on Wednesday, with investors still reeling from surprisingly hawkish comments by US Fede...

Redx Pharma shares slide on RXC004 monotherapy blow
8 Mar 2023

Redx Pharma shares slide on RXC004 monotherapy blow

(Alliance News) - Redx Pharma PLC on Wednesday said first results of its phase 2 programme indicate were not sufficient enough to support the developm...

AIM WINNERS & LOSERS: Redx drops on disappointing cancer drug results
8 Mar 2023

AIM WINNERS & LOSERS: Redx drops on disappointing cancer drug results

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.